The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Karen Jensen joins Scripps Health as director of the oncology clinical care line

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

KAREN JENSEN joined Scripps Health as director of the oncology clinical care line for the health system’s integrated cancer program.

For the past 21 years, Jensen held a variety of leadership roles in Mayo Clinic’s southwest Minnesota region. Most recently, she was vice president of quality and director of clinical outcomes, where she was responsible for improving quality and safety across patient care, including the implementation of a regional medical staff quality program.

Previously at Mayo Clinic, she served as vice president of organizational performance, learning and innovation; vice president of operations; chief financial officer; and director of patient flow.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

VCU Massey researchers discover TAF2 gene plays a pivotal role in HCC

Devanand Sarkar and a team of scientists at VCU Massey Comprehensive Cancer Center have discovered that the gene TAF2 plays a pivotal role in the growth of hepatocellular carcinoma. The researchers found that TAF2 is overexpressed in HCC patients compared to individuals with healthy livers, and that TAF2 regulates the survival of hepatocytes—the functional cells of the liver—and tumor formation. Their study—recently published in the journal Hepatology also demonstrates that TAF2 cooperates with the MYC gene, another known major driver of cancer, to accelerate tumor growth.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account